Highlights Jiangsu Nhwa Pharmaceutical Co., LTD

Equities

002262

CNE100000CG8

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-16 pm EDT			5-day change	1st Jan Change
23.69 ^CNY	+0.04%		-6.44%	-12.65%

Apr. 19	Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 03	Nhwa Pharma Gets Nod to Test NH103 Oxalate Tablets	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jiangsu Nhwa Pharmaceutical Co., Ltd Approves Cash Dividend for 2023, Payable on 15 May 2024	Apr. 24	CI
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19	CI
Nhwa Pharma Gets Nod to Test NH103 Oxalate Tablets	Apr. 03	MT
Jiangsu Nhwa Pharmaceutical Co., Ltd Proposes Profit Distribution for 2023	Apr. 01	CI
Nhwa Pharmaceutical's 2023 Profit Climbs 15% as Revenue Rises 17%	Apr. 01	MT
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 29	CI
Exchange-Traded Funds Higher, Equity Futures Lower Pre-Bell Monday Ahead of Data-Packed Week	Feb. 26	MT
Teva Pharmaceutical Investments Singapore Pte Ltd. and Jiangsu Nhwa Pharmaceutical Co., LTD Forge Strategic Partnership to Promote Patient Access to Austedo® in China	Feb. 26	CI
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25	CI
Jiangsu Nhwa Pharma’s H1 Profit Jumps 21.7% as Revenue Rises 20%	23-07-31	MT
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-30	CI
Wang Zeyu cancelled the acquisition of 13% stake in Jiangsu Farever Pharma Co., Ltd. from Jiangsu Nhwa Pharmaceutical Co., LTD.	23-07-27	CI
Jiangsu Nhwa Pharmaceutical Co., Ltd. Receives Formal Approval from the National Medical Products Administration for OLINVYK	23-05-08	CI
Jiangsu Nhwa Pharmaceutical Co., Ltd Approves Cash Dividend for 2022, Payable on 28 April 2023	23-04-17	CI
Jiangsu Nhwa Pharma’s Q1 Profit Jumps 20.5% as Revenue Rises 19%; Shares Jump 5%	23-04-14	MT
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-13	CI
Jiangsu Nhwa Pharmaceutical Co., LTD Proposes Final Cash Dividend for 2022	23-03-20	CI
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Mr Wang Zeyu agreed to acquire 13% stake in Jiangsu Farever Pharma Co., Ltd. from Jiangsu Nhwa Pharmaceutical Co., LTD for CNY11.4673 million.	22-07-29	CI
Jiangsu Nhwa Pharmaceutical Co., LTD Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-29	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Jiangsu Nhwa Pharmaceutical Co., LTD

Equities

002262

CNE100000CG8

Highlights

Filters